Introduction:

CRISPR Technology Market was valued at US$ 4.2 billion in 2024 and is projected to grow at a CAGR of 21% to reach US$ 28.4 billion by 2034.

CRISPR technology (clustered regularly interspaced short palindromic repeat) is a straightforward yet commanding tool for the purpose of editing genomes. CRISPR is a genome editing tool and Cas9 is an enzyme acting as “molecular scissors” cuts two strands of DNA at specific location so that DNA can be altered by adding or removing bits of DNA. CRISPR technology is preferred due to being versatile, efficient, and orthogonal. It enables researchers to alter DNA sequences without difficulty and further modify gene function.

It has several potential applications which include treating and preventing the spread of diseases, correcting genetic defects, and, improving crops. The CRISPR technology industry is focused on the development of gene therapeutics for the treatment of various genetic disorders such as thalassemia, hemophilia, and sickle cell anemia, among others. The increasing prevalence of genetic disorders is promoting the growth of the CRISPR technology, for better treatment and improved quality of life of patients.

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

Investment and Funding on CRISPR technology

Increasing investment creates a conductive environment for research and development in the field, leading to new discoveries and techniques propelling the CRISPR technology market. Increasing funding and investment helps in development of new products, expand the team and invest more in R&D. Scientists, researchers and companies are adopting CRISPR technology for precise editing and to get full access to difficult areas of human genome.

For instance, in February 2023, Bioscientists received investments to employ CRISPR-based gene editing to reduce the population of dangerous insects and provide a safer, more environmentally friendly substitute for pesticides.

Ethical Concerns and Regulatory guidelines

Ethical concerns related to genetic research and modifications expected to hinder the CRISPR technology. Possibility of off-target effects, lack of information, lack of skilled professionals could affect the targeted market.

CRISPR Technology Market is segmented based on Product, Application, End-User and Region.

By Product	By Application	By End-User	By Region
Enzymes Kits and Reagents  Guide RNA Others (Antibodies, Vectors, and Design Tools)	Biomedical Agricultural Industrial  Others	Pharmaceutical Companies Biotechnology Companies Academics Government Research Institutes  Other (CRO)	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa

 

Product Insights

On the basis of Product, the target market is segmented into Enzymes, Kits and Reagents, Guide RNA, and Others (Antibodies, Vectors, and Design Tools). Enzymes Segment is expected to dominate the CRISPR technology market over the forecast period and this is attributed to the increase in demand or adoption of CRISPR technology. Cas9 enzymes together with CRISPR sequences form the basis of the technology known as CRISPR-Cas9 that can be used to edit genes within organisms.

Application Insights

On the basis of Application, the target market is segmented into Biomedical, Agricultural, Industrial, and Others. CRISPR being a promising technology that could offer new treatments for diseases, Biomedical Segment is expected to dominate CRISPR technology the market over the forecast period and this is attributed to the increase in globe disease burden and need for novel approaches and therapeutics for treatment.

End-user Insights

On the basis of End-user, the target market is segmented into Pharmaceutical Companies and Biotechnology Companies, Academics and Government Research Institutes, and Other (CRO).Pharmaceutical and Biotechnology Companies Segment is expected to dominate the market over the forecast period and this is attributed to the expanding biopharmaceutical R&D and active engagement of various pharmaceutical and biotechnology companies in the development of novel therapies.

Regional Insights:

Disclaimer: This data is only a representation. Actual data may vary and will be available in the report.

On region the target market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

• North America market is estimated to witness a significantly high revenue share over the forecast period due to rising growth in biotechnological and pharmaceutical industries and infrastructure, technological advancements, demand for precise medicines and treatments, robust advancements and adoption of biotechnology, investment and funding in healthcare boosts the CRISPR technology market In the region. Key players in the region also corresponds to the growth and expansion of the targeted market. Agricultural sector also plays a great role in expansion of CRISPR technology market due to development of CRISPR-edited crops and its commercialization. For instance in April 2021, researchers from MIT, Massachusetts Institute of Technology along with University of California created a CRISPR on-off switch regulating gene expression.
• Asia Pacific market is estimated to witness a fastest revenue share over the forecast period due to developments in new technologies for treating human and animal diseases. Rapid growth in economy along with diversified population and large patient pool, favors expansion of CRISPR technology market in the region.

Report Scope:

Attribute	Details
Market Size 2024	US$ 4.2 billion
Projected Market Size 2034	US$ 28.4 billion
CAGR Growth Rate	21%
Base year for estimation	2023
Forecast period	2024 – 2034
Market representation	Revenue in USD Billion & CAGR from 2024 to 2034
Market Segmentation	By Product - Enzymes, Kits and Reagents, Guide RNA, and Others (Antibodies, Vectors, and Design Tools By Application - Biomedical, Agricultural, Industrial, and Others By End User - Pharmaceutical Companies and Biotechnology Companies, Academics and Government Research Institutes, and Other (CRO)
Regional scope	North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends

Segments Covered in the Report:

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2024 to 2034. For the purpose of this study, has segmented the CRISPR Technology Market report based on Product, Application, End User and region:

CRISPR Technology Market, By Product:

• Enzymes
• Kits and Reagents
• Guide RNA
• Others (Antibodies, Vectors, and Design Tools)

CRISPR Technology Market, By Application:

• Biomedical
• Agricultural
• Industrial
• Others

CRISPR Technology Market, By End User:

• Pharmaceutical Companies and Biotechnology Companies
• Academics and Government Research Institutes
• Other (CRO)

 

CRISPR Technology Market, By Region:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa
  • GCC
  • Israel
  • South Africa
  • Rest of Middle East & Africa

The key players operating the CRISPR Technology Market includes

• Cellecta, Inc.
• GeneCopoeia, Inc.
• GenScript
• Horizon Discovery Group
• Integrated DNA Technologies
• Merck KGaA
• New England Biolabs
• Origene Technologies, Inc.
• Thermo Fisher Scientific
• Agilent Technologies

Recent Development:

 The New Launched Product News,

• In August 2023, FDA grants Fast Track designation to EBT-101. This designation underscores the importance of finding a cure for people living with HIV and bolsters Excision's efforts to rapidly develop potentially curative therapies for significant unmet medical needs.EBT-101 is a potentially curative, 1-time treatment which uses an adeno-associated virus (AAV) to deliver CRISPR-Cas9 and dual guide RNAs to target 3 sites in the HIV genome, make 2 cuts in integrated retroviral DNA that remove large portions of the HIV genome, and ultimately prevent viral escape and reproduction.
• In December 2023, FDA approved Casgevy, first CRISPR based therapy for Sickle cell anemia sponsored by Vertex Pharmaceuticals. U.K. became the first country to approve Casgevy. This news drew enthusiastic reactions from many scientists and stakeholders, including the CRISPR gene editing Nobel laureates, Jennifer Doudna, PhD, and Emmanuelle Charpentier, PhD.

• Agilent Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• Cellecta Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• GeneCopoeia Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Genscript
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Horizon discovery Group.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Integrated DNA Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Merck KGaA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• New England Biolabs
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
• Origene Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Thermo Fisher Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

"

1. Research Objective and Assumption
   • Preface
   • Research Objectives
   • Study Scope
   • Years Considered for the study
   • Assumptions
   • Abbreviations
2. Research Methodology
   • Research data
   • Primary Data
     • Primary Interviews
     • Primary Breakdown
     • Key data from Primary Sources
     • Key Thickness Insights
   • Secondary Data
     • Major Secondary Sources
     • Secondary Sources
   • Market Estimation
   • Top-Down Approach
     • Approach for estimating Market Share by Top-Down Analysis (Supply Side)
   • Bottom-Up Approach
     • Approach for estimating market share by Bottom-up Analysis (Demand Side)
   • Market Breakdown and Data Triangulation
   • Research Assumptions
   • PORTER’s
   • Investment Outlook
3. Market Preview
   • Executive Summary
   • Key Findings—Global Outlook for CRISPR Technology Strategies
     • Key Questions this Study will Answer

     • Market Segmentation, By Product:

       • Enzymes
       • Kits and Reagents
       • Guide RNA
       • Others
         • Antibodies
         • Vectors
         • Design Tools

       Market Segmentation, By Application:

       • Biomedical
       • Agricultural
       • Industrial
       • Others

       Market Segmentation, By End User:

       • Pharmaceutical Companies and Biotechnology Companies
       • Academics and Government Research Institutes
       • Other
         • CRO
   • Opportunity Map Analysis
   • Executive Summary—3 Big Predictions
4. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
     • Market Trends
   • DR Impact Analysis
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Opportunity Orbit
   • Overview
   • Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
   • Y-o-Y Growth Analysis (%), 2020 – 2030
   • Regional Trends
   • Market Investment Feasibility Index
   • Macroeconomic Factor Analysis
5. Regional Analysis
   • Regional Revenue Analysis
   • Regional By segment Analysis
   • Reasons for regional growth
   • Key Player of particular region
   • Countries Include in the report:

1. • • North America (U.S., Canada)
     • Europe (UK, France, Germany, Russia, Italy, Rest of Europe)
     • Asia Pacific (India, Japan, South Korea, China, Rest of Asia Pacific)
     • Latin America (Brazil, Mexico, Rest of Latin America)
     • Middle East & Africa (GCC, Israel, South Africa, Rest of Middle East)

1. Competitive Landscape
   • Heat Map Analysis
   • Market Presence and Specificity Analysis
   • Competitive Overview
   • Competitive Benchmarking
   • Market Share Analysis
   • Key Developments In The Global CRISPR Technology Market
   • Key Developments: Mergers & Acquisitions
   • Key Developments: Collaboration
   • Key Developments: Contracts & Agreements
   • Key Developments: Expansion
   • Key Developments: Product Developments
2. Company Profiles

• Agilent Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• Cellecta Inc
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• GeneCopoeia Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Genscript
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Horizon discovery Group.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Integrated DNA Technologies
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Merck KGaA
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• New England Biolabs
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
• Origene Technologies, Inc.
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies
• Thermo Fisher Scientific
  • Company Overview
  • Product Portfolio
  • Key Highlights
  • Financial Overview
  • Business Strategies

• Agilent Technologies

1. The Last Word
   • Future Impact
   • About Us
   • Contact